177 related articles for article (PubMed ID: 30644854)
21. Exploring the association of hemoglobin level and adverse events in children with cancer presenting with fever in neutropenia.
Ammann RA; Niggli FK; Leibundgut K; Teuffel O; Bodmer N
PLoS One; 2014; 9(7):e101696. PubMed ID: 25020130
[TBL] [Abstract][Full Text] [Related]
22. Colony-stimulating factors for the management of neutropenia in cancer patients.
Dale DC
Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
[TBL] [Abstract][Full Text] [Related]
23. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
Alali M; Mayampurath A; Dai Y; Bartlett AH
Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
[TBL] [Abstract][Full Text] [Related]
24. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
Mayordomo JI; López A; Viñolas N; Castellanos J; Pernas S; Domingo Alonso J; Frau A; Layola M; Antonio Gasquet J; Sánchez J;
Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781
[TBL] [Abstract][Full Text] [Related]
25. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
[TBL] [Abstract][Full Text] [Related]
26. Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.
Blay JY; Chauvin F; Le Cesne A; Anglaret B; Bouhour D; Lasset C; Freyer G; Philip T; Biron P
J Clin Oncol; 1996 Feb; 14(2):636-43. PubMed ID: 8636781
[TBL] [Abstract][Full Text] [Related]
27. Risk predictors for adverse outcome in pediatric febrile neutropenia: Single center experience from a low and middle-income country.
Prasad M; Chinnaswamy G; Arora B; Vora T; Hawaldar R; Banavali S
Indian J Cancer; 2014; 51(4):432-7. PubMed ID: 26842150
[TBL] [Abstract][Full Text] [Related]
28. Early hospital discharge of children with fever and neutropenia: a prospective study.
Wacker P; Halperin DS; Wyss M; Humbert J
J Pediatr Hematol Oncol; 1997; 19(3):208-11. PubMed ID: 9201142
[TBL] [Abstract][Full Text] [Related]
29. Fever and neutropenia outcomes and areas for intervention: A report from SUCCOUR - Supportive Care for Children with Cancer in Africa.
Israels T; Afungchwi GM; Klootwijk L; Njuguna F; Hesseling P; Kouya F; Paintsil V; Landman L; Chitsike I; Chagaluka G; Sung L; Molyneux E
Pediatr Blood Cancer; 2021 Sep; 68(9):e29224. PubMed ID: 34245212
[TBL] [Abstract][Full Text] [Related]
30. Microbiology and mortality of pediatric febrile neutropenia in El Salvador.
Gupta S; Bonilla M; Gamero M; Fuentes SL; Caniza M; Sung L
J Pediatr Hematol Oncol; 2011 May; 33(4):276-80. PubMed ID: 21516023
[TBL] [Abstract][Full Text] [Related]
31. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
[TBL] [Abstract][Full Text] [Related]
32. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
[TBL] [Abstract][Full Text] [Related]
33. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
Delebarre M; Gonzales F; Behal H; Tiphaine A; Sudour-Bonnange H; Lutun A; Abbou S; Pertuisel S; Thouvenin-Doulet S; Pellier I; Mansuy L; Piguet C; Paillard C; Blanc L; Thebaud E; Plantaz D; Blouin P; Schneider P; Guillaumat C; Simon P; Domenech C; Pacquement H; Le Meignen M; Pluchart C; Vérite C; Plat G; Martinot A; Duhamel A; Dubos F
Lancet Child Adolesc Health; 2022 Apr; 6(4):260-268. PubMed ID: 34871572
[TBL] [Abstract][Full Text] [Related]
34. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
Choi CW; Sung HJ; Park KH; Yoon SY; Kim SJ; Oh SC; Seo JH; Kim BS; Shin SW; Kim YH; Kim JS
Am J Hematol; 2003 Aug; 73(4):263-6. PubMed ID: 12879430
[TBL] [Abstract][Full Text] [Related]
35. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
36. Meropenem monotherapy as an empirical treatment of febrile neutropenia in childhood cancer patients.
Erbey F; Bayram I; Yilmaz S; Tanyeli A
Asian Pac J Cancer Prev; 2010; 11(1):123-6. PubMed ID: 20593941
[TBL] [Abstract][Full Text] [Related]
37. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
Brack E; Bodmer N; Simon A; Leibundgut K; Kühne T; Niggli FK; Ammann RA
Pediatr Blood Cancer; 2012 Sep; 59(3):423-30. PubMed ID: 22271702
[TBL] [Abstract][Full Text] [Related]
38. Outcome prediction in pediatric fever in neutropenia: Development of clinical decision rules and external validation of published rules based on data from the prospective multicenter SPOG 2015 FN definition study.
Santschi M; Ammann RA; Agyeman PKA; Ansari M; Bodmer N; Brack E; Koenig C
PLoS One; 2023; 18(8):e0287233. PubMed ID: 37531403
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre.
Schelenz S; Giles D; Abdallah S
Ann Oncol; 2012 Jul; 23(7):1889-93. PubMed ID: 22048152
[TBL] [Abstract][Full Text] [Related]
40. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
